Suppr超能文献

组织蛋白酶 L 基因多态性与利福平抗结核治疗早期失败的关系:一项荟萃分析

Global polymorphism of histidine rich proteins 2/3 and impact on malaria rapid diagnostic test detection: a systematic review and meta-analysis.

机构信息

Parasite and Host Biology Group, ICMR-National Institute of Malaria Research, Dwarka, India.

出版信息

Expert Rev Mol Diagn. 2023 Jul-Dec;23(10):925-943. doi: 10.1080/14737159.2023.2255136. Epub 2023 Sep 12.

Abstract

BACKGROUND

This review presents an overview of field findings on sequence variation of histidine-rich proteins 2/3 (HRP2/3) for which reference types (1-24) have been identified, and its critical impact on HRP2-based rapid diagnostic test (RDT) detection.

RESEARCH DESIGN AND METHODS

This systematic review and meta-analysis was registered with PROSPERO, CRD42022316027, and conducted as per the PRISMA guidelines, and the methodological quality of studies was assessed.

RESULTS

Of the 2184 records identified, 34 studies were included mostly from Africa (47.1%) and Asia (35.3%). The reference HRP2 types 1, 2, 3, 6, and 7 are invariably found at proportions ≥ 80-100% in all areas with the exception of The Americas where their proportion is very low. The proteins exhibited high diversity of variants/unknown types, especially for types 1, 2, 4, and 7. Eleven major HRP2 epitopes were found at pooled proportion > 90%. The existing models to predict RDT detection are greatly limited by the impact of factors such as low (very low) parasitemia, RDT brand, and HRP3 cross-reactivity. HRP2 length and presence/number of a given reference repeat type/variant did not seem to impact RDT detection.

CONCLUSIONS

HRP2/3 are highly polymorphic and current findings are insufficient, conflicting and not convincing enough to conclude on the role of HRP2/3 sequence polymorphism in HRP2-based RDT detection.

摘要

背景

本综述介绍了组氨酸丰富蛋白 2/3(HRP2/3)序列变异的实地研究结果概述,其中已确定参考类型(1-24),并对其对基于 HRP2 的快速诊断检测(RDT)检测的关键影响进行了探讨。

研究设计和方法

本系统评价和荟萃分析已在 PROSPERO 中注册,注册号为 CRD42022316027,并按照 PRISMA 指南进行,同时评估了研究的方法学质量。

结果

在确定的 2184 条记录中,有 34 项研究被纳入,其中大部分来自非洲(47.1%)和亚洲(35.3%)。参考 HRP2 类型 1、2、3、6 和 7 在所有地区的比例均始终≥80-100%,除了美洲,其比例非常低。这些蛋白质表现出高度的变异/未知类型多样性,特别是类型 1、2、4 和 7。11 个主要的 HRP2 抗原表位在汇总比例>90%时被发现。现有的预测 RDT 检测的模型受到许多因素的影响,如低(非常低)疟原虫血症、RDT 品牌和 HRP3 交叉反应性,极大地受到限制。HRP2 长度和给定参考重复类型/变异的存在/数量似乎并不影响 RDT 检测。

结论

HRP2/3 高度多态性,目前的研究结果不足、相互矛盾,且不够令人信服,无法得出 HRP2/3 序列多态性在基于 HRP2 的 RDT 检测中的作用的结论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验